Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Lung Cancer treatment details. Biologic therapy. Chemotherapy. The Arthur G James Cancer Hospital and Richard J Solove Research Institute, Columbus, OH, United States

Survival: 10.4 months
Toxicity Grade: 5
Treatments: Biologic therapy
Country: United States
City/State/Province: Columbus, OH
Hospital: The Arthur G James Cancer Hospital and Richard J Solove Research Institute
Journal: Link
Date: 11/2008

Patients: This phase 2 study involved patients with advanced non-small-cell lung cancer. They ranged in age from 36 to 78 years of age. There were two groups of patients; one group had 39 people in it, and they had not been treated with chemotherapy before. The other group had 15 patients, who had been treated with chemotherapy before and their cancer was resistant to it.

Treatment: Patients in both groups were treated with suramin, which is a biological therapy, and the chemotherapy drugs paclitaxel and carboplatin.

Toxicity: Two patients died unexpectedly, but these deaths were not attributed to the study drugs. Grade 4 neutropenia occurred in 53% of patients. Two patients experienced grade 4 fatigue/asthenia and 3 patients experienced grade 4 anemia. Grade 3 toxicities included neutropenia, anemia, thrombocytopenia, nausea, vomiting, diarrhea, fatigue, constipation, and peripheral neuropathy.

Results: The median overall survival was 10.4 months for patients that hadnít been treated with chemotherapy before, and 4.3 months (132 days) for the group that had been previously been treated with chemotherapy.

Correspondence: Dr. Miguel A. Villalona-Calero

E-mail to a Friend Email Physician More Information